Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma

Annals of Surgery

Volumn 250, Issue 2, 2009, Pages 242-246

  Kuramoto, Masafumi ^a   Shimada, Shinya ^e   Ikeshima, Satosi ^a   Matsuo, Akinobu ^a   Yagi, Yasushi ^b   Matsuda, Masakazu ^b   Yonemura, Yutaka ^c   Baba, Hideo ^d  

^a Yatsushiro Social Insurance General Hospital   (Japan)

^b National Hospital Organization   (Japan)

^c Kishiwada Tokushukai Hospital   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

^e Yatsushiro General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OVERALL SURVIVAL; PERITONEUM LAVAGE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; STANDARD; STOMACH CARCINOMA; CANCER INVASION; CARCINOMA; DISEASE FREE SURVIVAL; GASTRECTOMY; METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PERITONEUM TUMOR; STOMACH TUMOR;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; STOMACH NEOPLASMS;

EID: 68949106060     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181b0c80e     Document Type: Article

References (35)

1. Balfour DC. Factors of significance in the prognosis of cancer of the stomach. Ann Surg. 1973;105:733-740.
2. Kodera Y, Nakanishi H, Yamamura Y, et al. Prognostic value and clinical implications of disseminated cancer cells in the peritoneal cavity detected by reverse transcriptase-polymerase chain reaction and cytology. Int J Cancer. 1998;79:429-433.
3. Ikeguchi M, Matsumoto S, Yoshida S, et al. Laparoscopic-assisted intraperiotneal chemotherapy for the patients with scirrhous gastric cancer. Chemotherapy. 2005;51:15-20.
4. Hiratsuka M, Iwanaga T, Furukawa H, et al. Important prognostic factors in surgically treated gastric cancer patients. Jpn J Cancer Chemother. 1995;22: 703-708.
5. Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87:236-242.
6. Kimura Y, Hayashi K, Sasagawa T, et al. Pilot study of S-1 in patients with disseminated gastric cancer. Drugs Exp Clin Res. 2003;29:125-130.
7. Kunisaki C, Shimada H, Akiyama H, et al. Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis. Hepatogastroenterlogy. 2006;53:473-478.
8. Kunisaki C, Shimada H, Nomura M, et al. Lack of efficacy of prophylactic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancer. Surgery. 2002;131:521-528.
9. Ishizoe S, Maruta F, Saito H, et al. Efficacy of S-1 for patients with peritoneal metastasis of gastric cancer. Chemotherapy. 2006;52:301-307.
10. Suhsien L, Bart EM, Stuart GM, et al. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patients subgroups? J Surg Oncol. 2007;95:118-122.
11. Ribeiro U Jr, Gama-Rodrigues JJ, Safatle-Ribeiro AV, et al. Prognostic significance of intraperitoneal free cancer cells obtained by laparoscopic peritoneal lavage in patients with gastric cancer. J Gastrointest Surg. 1998; 2:244-249.
12. Ikeguchi M, Oka A, Tsujitani S, et al. Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res. 1994;14:2131-2134.
13. Boku T, Nakane Y, Minoura T, et al. Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg. 1990;77:436-439.
14. Bando E, Yonemura Y, Takeshita Y, et al. Intraoperative lavage for cytological examination in 1297 patients with gastric carcinoma. Am J Surg. 1999; 178:256-262.
15. Marutsuka T, Shimada S, Shiomori K, et al. Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis. Clin Cancer Res. 2003;9:678-685.
16. Shimada S, Tanaka E, Marutsuka T, et al. Extensive intraoperative peritoneal lavage and chemotherapy for gastric cancer patients with peritoneal free cancer cells. Gastric Cancer. 2002;5:168-172.
17. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma. 1st English ed. Tokyo, Japan: Kanehara; 1999.
18. Heslin M, Latkany L, Leung D, et al. A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg. 1997;226:567-580.
19. Papanicolaou GN. Atlas of Exfoliative Cytology. Cambridge, UK: Harvard University Press; 1963.
20. Fink A, Longmire W. Carcinoma of stomach. In: Subiston DC, ed. Textbook of Surgery. 14th ed. Philadelphia, PA: WB Saunders; 1991:814-827.
21. Ulysses R Jr, Adiana VS, Bruno Z, et al. Does the intraoperative peritoneal lavage cytology add prognostic information in patients with potentially curative gastric resection? J Gastrointest Surg. 2006;10:170-177.
22. Nakagawa A, Nashimoto A, Yabusaki H. Role of staging laparoscopy with peritoneal lavage cytology of locally advanced gastric cancer. Gastric Cancer. 2007;10:29-34.
23. Cheng-Chung Wu, Jung-Ta Chen, Ming-Cheng Chang, et al. Optimal surgical strategy for potentially curable serosainvolved gastric carcinoma with intraperitoneal free cancer cells. J Am Coll Surg. 1997;184:611-617.
24. Hayes N, Wayman J, Wadehra V, et al. Peritoneal cytology in the surgical evaluation of gastric carcinoma. Br J cancer. 1999;79:520-524.
25. Yamamura Y, Ito S, Mochizuki Y, et al. Distribution of free cancer cells in the abdominal cavity suggests limitation of bursectomy as an essential component of radical surgery for gastric carcinoma. Gastric Cancer. 2007; 10:24-28.
26. Mori T, Fujikawa Y, Sugita Y, et al. Application of molecular diagnosis for detection of peritoneal micrometastasis and evaluation of preoperative chemotherapy in advanced gastric carcinoma. Ann Surg Oncol. 2004;11:14-20.
27. Kodera Y, Yamamura Y, Shimizu Y, et al. Peritoneal washing cytology: Prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol. 1999;72:60-65.
28. Rosenberg R, Nekarda H, Bauer P, et al. Free peritoneal tumor cells are an independent prognostic factor in curatively resected stage 1B gastric carcinoma. Br J Surg. 2006;93:325-331.
29. Tsujitani S, Okuyama T, Watanabe A, et al. Intraperitoneal cisplatin during surgery for gastric cancer and peritoneal seeding. Anticancer Res. 1993;13: 1831-1834.
30. Fujimoto S, Takahashi M, Mutou T, et al. Successful intraperiotneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer. 1999;85:529-534.
31. Budgwell B, Cormier J, Krishnan S, et al. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol. 2008;15:2684-2691.
32. Tamura N, Iinuma H, Takada T. Prospective study of the quantitative carcinoembryonic antigen and cytokeratin 20 mRNA detection in peritoneal washes to predict peritoneal recurrence in gastric carcinoma patients. Oncol Rep. 2007;17:667-672.
33. Benevolo M, Mottolese M, Cosomelli M, et al. Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer. J Clin Oncol. 1998; 16:3406-3411.
34. Kodera Y, Nakanishi H, Ito S, et al. Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction. Ann Surg. 2002;235:499-506.
35. Yamamoto K, Shimada S, Hirota M, et al. EIPL(extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer. Int J Oncol. 2005;27: 1321-1328.